Updates in Psoriasis Management 2020 Based on Selected Presentations from Maui Derm 2020 January 25–29, 2020, Maui, Hawaii by Jo Ann LeQuang Ms. Lequang is Owner of LeQ Medical in Angleton, Texas; Director of Scientific Communications at NEMA Research, Inc., in Naples, Florida; and Founding Director of No Baby Blisters in Colorado Springs, Colorado. J
J Clin Aesthet Dermatol. 2020;13(5):48–53 by Paul Macklis, MS; Kevin Adams, BA; Jessica Kaffenberger, MD; Purnima Kumar, BDS MS PhD; Andrew Krispinsky, MD; and Benjamin Kaffenberger, MD Mr. Macklis is with the Ohio State University College of Medicine in Columbus, Ohio. Mr. Adams with with the University of Toledo College of Medicine in Toledo, Ohio.
A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: The 2020 edition of the MauiDerm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically relevant material was also presented in poster format. For those of
Innovations in Psoriasis Management Based on Selected Presentations from Music City SCALE Symposium for Cosmetic Advances & Laser Education May 9–11, 2019, Nashville, Tennessee by Jo Ann LeQuang Owner, LeQ Medical, Angleton, Texas; Director of Scientific Communications, NEMA Research, Inc., Naples, Florida; Founding Director, No Baby Blisters, Colorado Springs, Colorado. J Clin Aesthet Dermatol 2019;12(12):S8–S19 Based on
J Clin Aesthet Dermatol. 2019;12(12):28–34 by Corinna E. Psomadakis, MBBS, and George Han, MD Drs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New York, New York. FUNDING: No funding was provided for this study. DISCLOSURES: Dr. Han has consulted for Regeneron, Sanofi Genzyme, Pfizer, Sun, and Janssen. Dr.